We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are OK with this.     OK  No, I would like to know more...
Home / Pharma Solutions / ADCs / ADC conjugation / Case study: Maleimide cysteine based ADC

Case study: Maleimide cysteine based ADC


Maleimide Cysteine Based ADC Thumbnail

Case study recording

Duration: 5 minutes

Abstract 

Antibody Drug Conjugates (ADCs) are fulfilling their promise as a new therapeutic class for the treatment of cancer.
However, ADCs are complex multicomponent molecules presenting unique manufacturing challenges.
In this case study, our expert Bertrand Cottineau explains how his team conducted process and analytical development to support Phase 1 cGMP manufacture of a maleimide cysteine based ADC.

What you will learn

- The project background and challenges
- The solution proposed by Novasep to answer customer needs: process development carried out and analytical methods developed
- The results

Speaker

Bertrand Cottineau 5

Bertrand Cottineau, Ph.D., PR&D group head (highly potent chemistry and bioconjugation), Novasep Le Mans, France. He completed a Ph.D. degree in organic chemistry at Orleans University in 2002. He has more than 15 years’ experience in process development for API and contributed to 9 scientific publications in international journals. He joined Novasep Le Mans in 2013 to lead the HPAPI process development group and is now responsible for both HPAPI and bioconjugation process development groups.

It's time to learn more about the process and analytical development of a maleimide cysteine based ADC!


To watch this case study recording, just fill the form below:

 
 
Downloads
  • Frequently Asked Questions: ADCs
    Frequently Asked Questions: ADCs
    Learn more about ADCs in our FAQ!
  • A full range of CDMO services for ADCs
    A full range of CDMO services for ADCs
    Find out the solution adapted to your needs with Novasep's fully integrated CDMO services for ADCs
  • Case study: Successful cGMP conjugation of a Phase I ADC
    Case study: Successful cGMP conjugation of a Phase I ADC
    Novasep was approached by a top 10 pharmaceutical company to help with the manufacture of a cGMP ant...
  • Case study: 1st ADC lead candidates to support pre-tox development program
    Case study: 1st ADC lead candidates to support pre-tox development program
    Novasep was approached by a biopharmaceutical company developing a preclinical ADC consisting of IgG...
Contact

A question ? A request ? Leave us a message !

Contact us
You can stay on this page and select more documents or you can directly download the brochure(s) you selected

Your brochure is ready!

X

You can stay on this page and select more documents or you can directly download the brochure(s) you selected

Give us your feedback!